Neal James R has filed 29 insider transactions across 3 companies since June 2023.
Most recent transaction: a purchase of 789 shares of Processa Pharmaceuticals, Inc. ($PCSA) on March 31, 2026.
Activity breakdown: 5 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | P | Common Stock | 789 | $2.54 | 818.0000 | 56,644,223 | 2720.69% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Director | P | Pre-Funded Warrants to purchase ADRs | 2473 | $0.40 | 2,473.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Director | P | Warrants to purchase ADRs | 3093 | $0.00 | 3,093.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Director | P | Pre-Funded Warrants to purchase ADRs | 3093 | $0.40 | 3,093.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Director | P | Warrants to purchase American Depositary Shares ("ADRs") | 2473 | $0.00 | 2,473.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | A | Stock Options (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 5,269,240 | 9999.99% | 5.69% |
| Oct. 1, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 5,269,240 | 9999.99% | 1.90% |
| Sept. 3, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | A | Restricted Stock | 31206 | $0.00 | 36,275.0000 | 0 | 615.62% | 0.00% |
| July 24, 2025 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | A | Restricted Stock | 175299 | $0.00 | 206,505.0000 | 5,269,240 | 561.75% | 3.33% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Series A Warrants (Right to Buy) | 4464 | $1.12 | 4,464.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Series B Warrants (Right to Buy) | 4464 | $1.12 | 4,464.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | American Depositary Shares representing Ordinary Shares | 4464 | $1.12 | 36,271.0000 | 0 | 14.03% | 0.00% |
| Jan. 9, 2025 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Ordinary Shares, par value $0.0001 per share | 8000000 | $0.00 | 32,216,000.0000 | 0 | 33.04% | 0.00% |
| Dec. 23, 2024 | Akari Therapeutics Plc | $AKTX | Neal James R | Not found | A | Ordinary Shares, par value $0.0001 per share | 2000000 | $0.00 | 24,216,000.0000 | 0 | 9.00% | 0.00% |
| Sept. 3, 2024 | Processa Pharmaceuticals, Inc. | $PCSA | Neal James R | Not found | A | Restricted Stock | 31206 | $0.00 | 31,206.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock Options | 6880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock Options | 12160 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Restricted Stock Units | 5820 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Restricted Stock Units | 5100 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock, par value $0.01 | 5820 | $0.00 | 10,920.0000 | 0 | 114.12% | 0.00% |
| Feb. 9, 2024 | PALISADE BIO, INC. | $PALI | Neal James R | Director | M | Common Stock, par value $0.01 | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | Neal James R | Director | A | Restricted Stock Units | 5820 | $0.00 | 5,820.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2023 | PALISADE BIO, INC. | $PALI | Neal James R | Director | A | Common Stock Options | 6880 | $0.00 | 6,880.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | PALISADE BIO, INC. | $PALI | Neal James R | Director | A | Common Stock Options | 12160 | $0.00 | 12,160.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2023 | PALISADE BIO, INC. | $PALI | Neal James R | Director | A | Restricted Stock Units | 5100 | $0.00 | 5,100.0000 | 0 | 9999.99% | 0.00% |